Crónicas de autores

Nancy Castellano *

Autor invitado por SIIC

El trabajo contribuye a resolver la controversia en torno al tratamiento de la hipertensión leve en ancianos

BENEFICIOS DEL USO DE INMUNOGLOBULINA INTRAVENOSA EN PATOLOGIAS INFLAMATORIAS

Para la determinación del tratamiento la diarrea aguda severa requiere evaluación médica inmediata y adecuado diagnóstico con técnicas de recolección de materia fecal. En caso de sospecha de infección invasiva el uso de agentes antibióticos y antidiarreicos es controvertido.

*Nancy Castellano
describe para SIIC los aspectos relevantes de su trabajo
CURRENT STATUS OF HUMAN PAPILLOMAVIRUS VACCINES
Journal of the Formosan Medical Association,
109(7):481-483 Jul, 2010

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*Universidad de Buenos Aires, Buenos Aires, Argentina
Imprimir nota
Comprar este artículo
Otros artículos escogidos
Referencias bibliográficas
1. Schwimmer JB. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. Semin Liver Dis 27:312-18, 2007.
2. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143:500-5, 2003.
3. Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 291:697-703, 2006.
4. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 43:413-27, 2006.
5. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 127:700-704, 1995.
6. Tominaga K, Kurata JH, Chen YK, Fugimoto E, Miyag awa S,Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 40:2002-9, 1995.
7. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 115:561-5, 2005.
8. Kahen T, Schwimmer JB, Lavine JE, Deutsch R, Stanley C, Behling C. Population prevalence of pediatric fatty liver disease. Gastroenterology 126:A753-4, 2004.
9. Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 24:772-6, 2000.
10. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes 50:2444-50, 2001.
11. Cook JS, Hoffman RP, Stene MA, Hansen JR. Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab 77:725-30, 1993.
12. Tanner JM. Worldwide variation in human growth. Cambridge: Cambridge University Press, 1990.
13. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from National high Blood Pressure Education Program. Pediatrics 98:649-658, 1996.
14. American Academy of Pediatrics, Committee on Nutrition. Cholesterol in childhood. Pediatrics 101:141-147, 1998.
15. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 28:S4-36, 2005.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-9, 1985.
17. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index (QUICKI) for epidemiological assessment and prevention. J Clin Endocrinol Metab 87:144-7, 2002.
18. Armellini F, Zamboni M, Rigo L, Bergamo-Andreis IA, Robbi R, Marchi M. Sonography detection of small intra-abdominal fat variations. Int J Obes 15:847-52, 1991.
19. Ribeiro Filho FSF. Identificaçao de indivíduos obesos de alto risco cardiovascular através da mensuraçao ultra-sonográfica da adiposidade visceral (tese). Universidade Federal de Sao Paulo, Sao Paulo, 2002.
20. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388-93, 2006.
21. Fishbein MH, Cox S. Non-alcoholic fatty liver in a toddler. Clin Pediatr (Phila) 43:483-5, 2004.
22. Kimata H. Increased incidence of fatty liver in non-obese Japanese children under 1 year of age with or without atopic dermatitis. Public Health 120:176-8, 2006.
23. Chan DFY, Li AM, Chu WCW, Chan MHM, Wong EMC, Liu EKH, et al. Hepatic steatosis in obese Chinese children. Int J Obes 28:1257-63, 2004.
24. Ortega E, Koska J, Salbe AD, Tataranni PA, Bunt JC. Serum c-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children. J Clin Endocrinol Metab 91:1419-22, 2006.
25. Manco M, Marcellini M, DeVito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes 32:381-87, 2008.
26. Schwimmer JB, Behling C, Newbury R, Deutsh R, Nievergelt C, Schork NJ, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42:641-9, 2005.
27. Schwimmer JB, Khorram O, Chiu V, Schwimmer WB. Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertil Steril 83:494-7, 2005.
28. Cerda C, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 47:412-17, 2007.
29. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89:61-70, 2004.
30. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 28:386-95, 2008.


ua40317